55 patents currently held
15 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
4 more records may belong here and await a decision; they are not counted.
The next term ends in Dec 2026. from the record
Of the 15 now held by other companies, 2 name Sloan Kettering Institute for Cancer Research as their current owner, and 13 more name another party. Each row says which.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
51
Ending by 2030
Dec 2026
Next term end
44
Patent families
When these terms end
Held patents by the year their term ends
notable patents
fee due within 90 days
all others
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends Aug 2029 · High confidence
Also notable
Ends Sep 2027 · High confidence
Also notable
Ends no later than Sep 2027 · Medium confidence
Also notable
Ends Jun 2028 · High confidence
Also notable
Ends Sep 2030 · High confidence
Also notable
Ends Jan 2027 · High confidence
Also notable
Ends Aug 2027 · High confidence
Also notable
Ends Jan 2028 · High confidence
Modular Fabrication Systems and Methods
US 7,939,003
Cited by 132 later US patents, top 5% of utility patents granted in 2011 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2029.
Nicotinoyl Riboside Compositions and Methods of Use
US 8,106,184
Cited by 85 later US patents, top 10% of utility patents granted in 2012 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2027.
Methods for Reducing Oxidative Damage
US 7,781,405
Cited by 27 later US patents, top 25% of utility patents granted in 2010 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2027. A terminal disclaimer is on file and its reference is not resolved, so no cap is applied and the date may move earlier, never later.
Photoluminescent Silica-Based Sensors and Methods of Use
US 8,084,001
The most cited patent in this portfolio, cited by 1,553 later US patents, top 1% of utility patents granted in 2011 in our data. Protection runs to 2028.
Compositions and Methods for the Display of Proteins on the Surface of Bacteria and Their Derived Vesicles and Uses Thereof
US 9,051,565
Cited by 29 later US patents, top 25% of utility patents granted in 2015 in our data, and renewed at every maintenance window due so far. Protection runs to 2030.
Methods for Reducing CD36 Expression
US 7,541,340
The largest patent family in this portfolio, 10 related applications, renewed at 3 of 3 maintenance windows. Protection runs to 2027.
Method and Carrier Complexes for Delivering Molecules to Cells
US 7,704,954
The largest patent family in this portfolio, 6 related applications, renewed at 3 of 3 maintenance windows. Protection runs to 2027.
Methods and Compositions for Promoting Survival and Proliferation of Endothelial Cells and Stimulating Angiogensis
US 10,865,379
A family of 6 related applications built on the 2020 grant. Protection runs to 2028. A terminal disclaimer caps this term to an earlier patent's.
Formerly held, still cited
Notable
Ends Oct 2028 · High confidence
Cited by 36 later US patents, top 25% of utility patents granted in 2011 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2028.
now held by University of Florida Research Foundation, Inc.
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Dec 9, 2026The maintenance fee for Compositions and Methods for the Display of Proteins on the Surface of Bacteria and Their Derived Vesicles and Uses Thereof (US 9,051,565) comes due Dec 9, 2026. Unpaid by Jun 9, 2027, it lapses early.
- 1 fee due Feb 4, 2027The maintenance fee for Adenylyl Cyclases as Novel Targets for the Treatment of Infection by Eukaryotic Pathogens (US 9,095,578) comes due Feb 4, 2027. Unpaid by Aug 4, 2027, it lapses early.
- 1 fee due Mar 12, 2027The maintenance fee for Method and System for Production of Adenosine Triphosphate (US 11,753,666) comes due Mar 12, 2027. Unpaid by Sep 13, 2027, it lapses early.
- 2 fees due Apr 1 to 6, 2027 · next Apr 1
- 1 fee due Jul 12, 2027The maintenance fee for Inhibition of Beta-Amyloid Peptide Aggregation (US 9,233,106) comes due Jul 12, 2027. Unpaid by Jan 12, 2028, it lapses early.
- 2 fees due Aug 4 to 27, 2027 · next Aug 4
Recent changes
- 1 of the patents on this record was granted since Aug 21, 2026
- 9 terms have ended since Aug 21, 2026
What they patent
The largest of its 44 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
Patents held now
Soonest term end first.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,564,809 | Event-Synchronization Protocol for Parallel Simulation of Large-Scale Wireless Networks In force · High confidence | In force | High confidence | |
| US 7,811,761 | Method for Identifying Progressive Rod-Cone Degeneration in Dogs In force · High confidence | In force | High confidence | |
| US 8,603,971 | Methods for Reducing CD36 Expression In force · Medium confidence | In force | Medium confidence | |
| US 7,541,340 | Methods for Reducing CD36 Expression In force · High confidence | In force | High confidence | |
| US 7,809,926 | Systems and Methods for Reconfiguring On-Chip Multiprocessors In force · High confidence | In force | High confidence | |
| US 7,569,709 | Low Pressure Carbonylation of Heterocycles In force · High confidence | In force | High confidence | |
| US 7,875,734 | Low Pressure Carbonylation of Heterocycles In force · High confidence | In force | High confidence | |
| US 9,417,166 | System and Method for Increased Cooling Rates in Rapid Cooling of Small Biological Samples In force · High confidence | In force | High confidence | |
| US 7,682,619 | Canine Influenza Virus In force · High confidence | In force | High confidence | |
| US 8,445,655 | Functional Nucleic Acid Ligands to Fluorescent Proteins In force · High confidence | In force | High confidence |
Also on record, not counted in the 55: 15 patents in force now held by others · 424 patents ended · 1 application pending · 230 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.